NDC Product
Human Prescription DrugProlia NDC 55513-710
- Generic Name
- Denosumab
- Dosage Form
- Injection
- Route
- Subcutaneous
- Marketing
- BLA
Active Listing
DENOSUMAB
UNII 4EQZ6YO2HI
Substance Identification & Data
This profile provides standardized clinical and technical data for Denosumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 4EQZ6YO2HI.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 615258-40-7 and the RxNorm Concept ID (RxCUI) 993449. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
Preferred Name
DENOSUMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
Molecular Formula
4EQZ6YO2HI
The specific atomic composition represented as a molecular structure string.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
8653
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
QQ-76
Identifier assigned by the United States Adopted Names Council.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Denosumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.
FDA Official Name
DENOSUMAB
DENOSUMAB-BBDZ
DENOSUMAB-BMWO
DENOSUMAB-BNHT
DENOSUMAB-DESU
DENOSUMAB-DSSB
DENOSUMAB-KYQQ
DENOSUMAB-MOBZ
DENOSUMAB-NXXP
DENOSUMAB-QBDE
Common Names & Synonyms
DENOSUMAB [EMA EPAR]
DENOSUMAB [INN]
DENOSUMAB [JAN]
DENOSUMAB [MART.]
DENOSUMAB [MI]
DENOSUMAB [PURPLE BOOK CDER]
DENOSUMAB [USAN]
DENOSUMAB [VANDF]
DENOSUMAB [WHO-DD]
DENOSUMAB BBDZ [WHO-DD]
DENOSUMAB BIOSIMILAR (CT-P41)
DENOSUMAB BIOSIMILAR (HLX-14)
DENOSUMAB BIOSIMILAR (JIANGSU T-MAB BIOPHARMA)
DENOSUMAB BIOSIMILAR (QL-1206)
DENOSUMAB BIOSIMILAR TK-006
DENOSUMAB BMWO [WHO-DD]
DENOSUMAB BNHT [WHO-DD]
DENOSUMAB DSSB [WHO-DD]
HLX 14 [WHO-DD]
IMMUNOGLOBULIN G2, ANTI-(HUMAN OSTEOCLAST DIFFERENTIATION FACTOR) (HUMAN MONOCLONAL AMG162 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL AMG162 LIGHT CHAIN, DIMER
IMMUNOGLOBULIN G2, ANTI-(HUMAN OSTEOCLAST DIFFERENTIATION FACTOR) (HUMAN MONOCLONAL AMG162 HEAVY CHAIN), DISULPHIDE WITH HUMAN MONOCLONAL AMG162 LIGHT CHAIN, DIMER
IMMUNOGLOBULIN G2, ANTI-(HUMAN RANK LIGAND) (HUMAN MONOCLONAL AMG162 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL AMG162 LIGHT CHAIN, DIMER
IMMUNOGLOBULIN G2, ANTI-(HUMAN RANK LIGAND) (HUMAN MONOCLONAL AMG162 HEAVY CHAIN), DISULPHIDE WITH HUMAN MONOCLONAL AMG162 LIGHT CHAIN, DIMER
Brand / Trade Names
AUKELSO
BILDYOS
BILPREVDA
BOMYNTRA
BONCRESA
BOSAYA
CONEXXENCE
ENOBY
JUBBONTI
JUBEREQ
OSENVELT
OSPOMYV
OSVYRTI
OZILTUS
PROLIA
STOBOCLO
WYOST
XBRYK
XGEVA
XTRENBO
Technical Codes
9MW-0311
9MW-0321
AMG162
AMG-162
CTP41
CTP-41
CT-P41
HLX14
HLX-14
MW-031
MW-032
QL1206
QL-1206
TK006
TK-006
NDC Products Containing DENOSUMAB
This unique ingredient identifier is listed as an ingredient or substance in the following products in the NDC directory:
